fe²⁺

N14G-Fe, the Fe3+ chelated form of N14G, can identify Mycobacterium tuberculosis in sputum samples from tuberculosis patients, exhibiting exceptional fluorescence properties. Additionally, N14G-Fe effectively traverses the cell wall and the inner membrane region where IrtAB is located.

Fe-TMPyP binds to the prion protein PrP and inhibits misfolding. Fe-TMPyP is also a peroxynitrite decomposition catalyst.

Notoginsenoside Fe (Ginsenoside Mb) is a natural compound found in Panax japlcus var.

FE-200041 is a peripheral efficacious kappa opioid agonist.

FE-999011 is a dipeptidyl peptidase IV inhibitor.

Notoginsenoside Fe (Standard) is a reference standard for research and analysis in studies involving Notoginsenoside Fe. Notoginsenoside Fe (Ginsenoside Mb) is a natural compound found in Panax japlcus var.

Fe(III)(TDCPP) chloride is a biochemical reagent that can be used as a biomaterial for life science related research and as a sulfonylation reagent for organic synthesis and drug discovery.

Elesclomol (STA-4783) is an oxidative stress inducer and a highly lipophilic copper ion carrier. Elesclomol induces apoptosis in tumor cells and is used in copper death related studies. Elesclomol also inhibits FDX1-mediated Fe-S cluster biosynthesis.

Metronidazole (Metronidazol) is a synthetic nitroimidazole derivative with antiprotozoal and antibacterial activities.

BFMO (biogenic Fe-Mn oxides) (N,N'-Difurfuryloxamide) could eliminate or decrease Fe(II), Mn(II), and As(III&V) species simultaneously. Moreover, BFMO (biogenic Fe-Mn oxides) can be used for As removal from water containing high concentrations of Fe(II) and Mn(II).

Degarelix is a peptide and selective GnRH (human gonadotropin-releasing hormone) receptor antagonist that treats prostate cancer by lowering testosterone levels in the body.

Deferasirox (Fe3+ chelate) is an orally available iron chelator with potential anticancer activity, inhibits the anti-apoptotic activity of MCL-1, and can be used to study iron overload.

Fe (III) Etioporphyrin I chloride, a porphyrin compound, is widely used as a component in thin-film electronic devices. Additionally, Etioporphyrin I is employed in studies concerning crystal growth rates.

Selepressin, an analog of vasopressin, is a potent, selective vasopressin V1a receptor agonist.

FE-999024 is a selective tissue kalkinase-like inhibitor that significantly inhibits plasma kalkinase-like activity in the pancreas.

Fe-Cap folic is an encapsulated dosage for use as an iron supplement in pregnancy.

Iron Dextran (Fero Gradumet) is an iron supplement, used in the study of iron deficiency anemia.

Difelikefalin (CR-845; FE-202845) is a peripherally restricted, selective kappa opioid receptor (KOR) agonist with anti-inflammatory properties, demonstrating potential for modulating pruritus in chronic kidney disease.

L-Mimosine (Leucenol) is an antineoplastic alanine-substituted pyridine derivative isolated from Leucena glauca and acts as an iron chelator.

Barusiban is an oxytocin receptor antagonist.

Difelikefalin TFA is a κ-opioid receptor (KOR) agonist. It activates KOR in HEK293 cells expressing the human receptor (EC50 = 0.16 nM in a transactivation assay) and inhibits forskolin-induced cAMP production in R1.G1 mouse thyoma cells (EC50 = 0.048 nM). Difelikefalin TFA is selective for KOR over the μ-opioid receptor (MOR; EC50 = >1 µM in a transactivation assay). It reduces acetic acid-induced writhing, as well as scratching behavior induced by the KOR antagonist GNTI, in mice (ED50s = 0.07 and 0.05 mg/kg, respectively).

Difelikefalin HCl is a κ-opioid receptor (KOR) agonist. It activates KOR in HEK293 cells expressing the human receptor (EC50 = 0.16 nM in a transactivation assay) and inhibits forskolin-induced cAMP production in R1.G1 mouse thyoma cells (EC50 = 0.048 nM). Difelikefalin HCl is selective for KOR over the μ-opioid receptor (MOR; EC50 = >1 µM in a transactivation assay). It reduces acetic acid-induced writhing, as well as scratching behavior induced by the KOR antagonist GNTI, in mice (ED50s = 0.07 and 0.05 mg/kg, respectively).

RK-52 is a synthetic inhibitor of rhodesain, characterized by an impressive ksecond value (ksecond = 67000 × 103 M−1 min−1) and by a picomolar affinity toward the trypanosomal protease (Ki = 38 pM).

Nordimaprit is effective agonist in the inhibition of lymphocyte activation.